Welcome to BusinessBankruptcies.com!

Sign up for a free account to get access to data on case creditors, search for cases, and more.

Orexigen Therapeutics, Inc.

COURT
Delaware Bankruptcy Court
CASE NUMBER
1:2018bk10518
TYPE / CHAPTER
Voluntary / 11

Filed

3-12-18

Updated

11-17-24

Last Checked

4-3-18

Assets

Subscribe

Liabilities

Subscribe

Docket

Last Updated
Mar 12, 2018
Last Entry Filed
Mar 12, 2018

Docket Entries by Year

Mar 12, 2018 1 Petition Chapter 11 Voluntary Petition of Orexigen Therapeutics, Inc.. Fee Amount $1717. Filed by Orexigen Therapeutics, Inc.. (Bibiloni, Jose) (Entered: 03/12/2018)
Mar 12, 2018 2 Receipt of filing fee for Voluntary Petition (Chapter 11)(18-10518) [misc,volp11a] (1717.00). Receipt Number 8787262, amount $1717.00. (U.S. Treasury) (Entered: 03/12/2018)
Mar 12, 2018 3 Affidavit/Declaration in Support of First Day Motion of Michael A. Narachi in Support of First Day Relief Filed By Orexigen Therapeutics, Inc. (Bibiloni, Jose) (Entered: 03/12/2018)
Mar 12, 2018 4 Motion to Approve Debtor In Possession Financing Filed By Orexigen Therapeutics, Inc. (Attachments: # 1 Exhibit A)(Bibiloni, Jose) (Entered: 03/12/2018)
Mar 12, 2018 5 Application to Appoint Claims/Noticing Agent KURTZMAN CARSON CONSULTANTS, LLC Filed By Orexigen Therapeutics, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B)(Bibiloni, Jose) (Entered: 03/12/2018)
Mar 12, 2018 6 Motion to Approve Motion For Entry Of Interim And Final Orders (I) Establishing Notice And Objection Procedures For Transfers Of Equity Securities And (II) Establishing A Record Date For Notice And Sell-Down Procedures For Trading In Claims Against The Debtor's Estate Filed by Orexigen Therapeutics, Inc.. (Attachments: # 1 Exhibit A # 2 Exhibit B) (Bibiloni, Jose) (Entered: 03/12/2018)
Mar 12, 2018 7 Motion to Maintain Bank Accounts Debtor's Motion For Entry Of Interim And Final Orders (A) Authorizing The Debtor to (I) Continue Its Cash Management Systems, (II) Honor Certain Related Prepetition Obligations, (III) Maintain Existing Business Forms, And (IV) Continue To Perform Intercompany Transactions, (B) Authorizing And Directing The Debtor's Banks To Honor All Related Payment Requests, (C) Granting Interim And Final Waivers Of The Debtor's Compliance With Section 345(b) Of The Bankruptcy Code, (D) Scheduling A Final Hearing, And (E) Granting Related Relief Filed By Orexigen Therapeutics, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B # 3 Exhibit C # 4 Exhibit D)(Bibiloni, Jose) (Entered: 03/12/2018)
Mar 12, 2018 8 Motion to Continue Customer Programs Debtor's Motion For Interim And Final Orders Pursuant To 11 U.S.C. §§ 105(a), 363, 1107, And 1108 And Fed. R. Bankr. P. 6003 And 6004 Authorizing Debtor To (I) Honor Certain Prepetition Obligations To Customers And To Continue Customer Programs And (II) Pay Medicaid And Other Obligations Filed By Orexigen Therapeutics, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B # 3 Exhibit C)(Bibiloni, Jose) (Entered: 03/12/2018)
Mar 12, 2018 9 Motion to Pay Employee Wages Motion Of The Debtor For Interim And Final Orders (I) Authorizing The Debtor To (A) Pay Prepetition Wages, Salaries, And Other Compensation (B) Pay Prepetition Payroll Taxes And Benefits And Continue Benefit Programs In The Ordinary Course, (II) Directing Banks To Honor Checks For Payment Of Prepetition Employee Payment And Program Obligations, And (III) Granting Related Relief Filed By Orexigen Therapeutics, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B)(Bibiloni, Jose) (Entered: 03/12/2018)
Mar 12, 2018 10 Motion to Pay Sales and Use Taxes Debtor's Motion For Entry Of Interim And Final Orders (I) Authorizing The Debtor To Pay Certain Preparation Taxes And Regulatory Fees In The Ordinary Course Of Business And (II) Authorizing Banks And Financial Institutions to Honor And Process Checks And Transfers Related Thereto Filed By Orexigen Therapeutics, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B # 3 Exhibit C)(Bibiloni, Jose) (Entered: 03/12/2018)
Mar 12, 2018 11 Motion to Authorize Debtor's Motion For Entry Of Interim And Final Orders (I) Authorizing Debtor To (A) Continue Prepetition Insurance Program; (B) Pay Any Prepetition Premiums And Related Obligations; And (C) Renew Or Enter Into New Insurance Arrangements; And (II) Granting Related Relief Filed by Orexigen Therapeutics, Inc.. (Attachments: # 1 Exhibit A # 2 Exhibit B # 3 Exhibit C) (Bibiloni, Jose) (Entered: 03/12/2018)

There are 5 newer docket entries.

To see the entire docket, login, subscribe now, or purchase this single case.

login purchase single case subscribe now

Case Information

Court
Delaware Bankruptcy Court
Case number
1:2018bk10518
Assets
Subscribe for Access
Liabilities
Subscribe for Access
Judge
Kevin Gross
Chapter
11
Filed
Mar 12, 2018
Type
voluntary
Updated
Nov 17, 2024
Last checked
Apr 3, 2018

Associated Cases

    This case has no creditors listed.

    Parties

    Debtor

    Orexigen Therapeutics, Inc.
    3344 N. Torrey Pines Court
    Suite 200
    La Jolla, CA 92037
    SAN DIEGO-CA
    Tax ID / EIN: xx-xxx8822

    Represented By

    Jose F Bibiloni
    Morris, Nichols, Arsht & Tunnell LLP
    1201 N. Market Street
    P.O. Box 1347
    Wilmington, DE 19899
    302-351-9472
    Fax : 302-425-4668
    Email: jbibiloni@mnat.com

    U.S. Trustee

    U.S. Trustee
    Office of the United States Trustee
    J. Caleb Boggs Federal Building
    844 King Street, Suite 2207
    Lockbox 35
    Wilmington, DE 19801
    (302)-573-6491

    Nearby Cases

    Date Filed Nameparent case = parent case Chapter Case #
    Sep 17 Silvergate Capital Corporation 11 1:2024bk12158
    Sep 17 Spring Valley Lots, LLC 11 1:2024bk12157
    Feb 13, 2023 Sorrento Therapeutics, Inc. 11 4:2023bk90085
    Aug 2, 2019 INTEGRATEDMARKETING.COM 11 3:2019bk04688
    Jul 1, 2019 Dr. James B. DeYarman D.O., Inc. 7 3:2019bk03954
    Mar 21, 2019 MabVax Therapeutics, Inc. parent case 11 1:2019bk10604
    Mar 21, 2019 MabVax Therapeutics Holdings, Inc. 11 1:2019bk10603
    Sep 29, 2017 Impeto Medical, Inc. 7 3:17-bk-05927
    Mar 2, 2016 Pediatric Bioscience, Inc. 7 3:16-bk-01185
    Feb 2, 2016 Metis Commercial Finance LLC 7 3:16-bk-00554
    May 27, 2014 PlayMG Corporation 7 3:14-bk-04139
    May 9, 2012 Lawson-Currell Centre, LLC 11 5:12-bk-53559
    Apr 23, 2012 Traversa Therapeutics, Inc. 7 3:12-bk-05752
    Dec 28, 2011 Torrey Pines Securities, Inc. 7 3:11-bk-20665
    Sep 13, 2011 Lava Sport & Fitness, LLC 7 3:11-bk-15226